Medical and pharmaceutical law: features of palliative care to the pharmaceutical correction of patients with pain syndromes
Journal Title: Фармацевтичний журнал - Year 2015, Vol 3, Issue 3
Abstract
Reform of the modern health care system is aimed at improving access to medicines for patients of different clinical and pharmacological classification, regulatory and legal nomenclature groups. It acquires special importance in the provision of health medical and pharmaceutical care those patients whose disease is incurable, and accompanied by the development of pain. For theese categories of patients (and their in Ukraine more than 400 thousand) at the legislative level, a dedicated view of the medical and pharmaceutical care - palliative care. Therefore, the aim of the work was to study the features of palliative care as a separate pharmaceutical correction of patients with pain from a position of medical and pharmaceutical law. To achieve this goal we used the following materials research: health legislation (Constitution, laws, orders of the Ministry of Health of Ukraine, forms of medicines at all levels), medical and technological documentation regarding the provision of palliative care. The study used the following methods: regulatory, documentary, method of systematic data and forensic pharmaceutical analysis. The study highlighted the category of patients in need of palliative care. The basic clinical and pharmacological group of drugs that are used to pharmaceutical correction pain in palliative patients and their distribution over the levels of anesthesia. It was established that in the provision of palliative care possible use of adjuvant drugs that target potentiating and prolongation of action of drugs with direct analgesic effect. The systematization of clinical and pharmacological groups adjuvant drugs in accordance with international anatomical-therapeutic and chemical classification system ATC. The study authors have outlined the main directions of improvement of palliative care, in particular adjuvant pharmaceutical correction by forming an official list of drugs that can be used as part of adjuvant pharmaceutical correction followed by corresponding changes in their instructions for medical use.
Authors and Affiliations
O. A. Ryschenko
Keywords
Related Articles
- EP ID EP586447
- DOI -
- Views 57
- Downloads 0
The microscopical investigation of diagnostic diseases of Thymus х Citriodorus var. «Silver Queen» herbs
The actual problem of modern pharmacy is the study of promising essential oil plant species with pronounced antimicrobial and anti-inflamattory activity for their further introduction in medical practice. Species of one...
The development of technology of Fludeoxyglucose (18F) for injection, laboratory analysis methods
18F-Fluorodeoxyglucose has optimal characteristics for use in nuclear medicine and is a priority among radiopharmaceuticals for the diagnosis of cancer by positron emission tomography (PET). 18F-Fluorodeoxyglucose has th...
Chromato-mass-spectrometric assessment of volatile components for nettle (Urtica dioica L.)
The species of nettle (Urtica dioica) are used long ago as hemostaticum for hemorrhages of various genesis both in non-traditional and in official medicine. Besides, the extractions of nettle possess hypolipidemic, chola...
Researches of the assortment of drugs for the treatment of diabetes II type оn the pharmaceutical market of Ukraine
Type II diabetes is a global pandemic, as evidenced by data from a study by the International Diabetes Federation. The disease is a chronic, progressive process with a special metabolic condition that is characterized by...
Pharmacoeconomic evaluation of glaucoma treatment by the «cost‒effectiveness» method
Primary open-angle glaucoma is one of the most common ocular pathologies that leads to irreversible vision loss in the absence of rational treatment. The disease is characterized by a high degree of disability and a sign...